Ebu Bekir Sıddık Yılmaz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fibrinogen-to-Albumin, Platelet-to-Albumin, and Creatinine-to-Albumin Ratios in the Assessment of Preeclampsia Severity: A Retrospective Case–Control Study

    by Hüseyin Kayaalp, Şeyhmus Tunc, Ebubekir Sıddık Yılmaz, Sedat Akgöl

    Background : Preeclampsia (PE) is a multisystem pregnancy disorder associated with endothelial dysfunction, inflammation, and coagulation abnormalities. This study evaluated the fibrinogen-to-albumin ratio (FAR), platelet-to-albumin ratio (PAR), and creatinine-to-albumin ratio (CrAR) in relation to preeclampsia severity. Methods: This single-center retrospective case–control study included 205 pregnant women: 104 healthy controls, 70 patients with non-severe PE, and 31 with severe PE. Clinical, obstetric, neonatal, and laboratory data were reviewed. Group comparisons, receiver operating characteristic (ROC) analysis, and logistic regression adjusted for maternal age, body mass index, and gestational age at sampling were performed. Results: Fibrinogen and FAR were significantly higher in severe than in non-severe PE. Fibrinogen showed an area under the curve of 0.685, with 67.7% sensitivity and 58.6% specificity at a cut-off of 5.05 g/L. FAR showed an area under the curve of 0.657, with 67.7% sensitivity and 64.3% specificity at a cut-off of 0.143. Both fibrinogen and FAR remained independently associated with severe PE after adjustment for maternal age, body mass index, and gestational age at sampling. FAR did not demonstrate superior discriminatory performance compared with fibrinogen alone. PAR did not differ significantly among groups, while CrAR was higher in preeclampsia than in controls but did not discriminate severe disease. Conclusions: Fibrinogen and FAR were associated with severe PE but demonstrated only modest discriminatory performance. FAR did not outperform fibrinogen alone, and its incremental value beyond fibrinogen remains uncertain. Therefore, these findings should be considered exploratory and do not support the use of FAR or fibrinogen as standalone tools for clinical screening, risk stratification, or decision-making. Further prospective, multicenter studies are needed to determine whether these markers provide clinically meaningful value within broader multimodal assessment models.

  • Diagnostic Performance of LDL/HDL, CRP/HDL, and Monocyte/HDL Ratios in Predicting Preeclampsia and Severe Preeclampsia

    by Ebu Bekir Siddik Yilmaz, Serenat Yalçın, Erkan Sağlam, Mustafa Raşit Özler

    Objective:Preeclampsia (PE) is a major complication of pregnancy and a leading cause of maternal and fetal morbidity and mortality worldwide. Hyperlipidemia and systemic inflammation are key components of its pathophysiology. This study aimed to evaluate the roles of LDL/HDL, CRP/HDL, and monocyte/HDL ratios in predicting PE and severe PE.Materials and Methods:This retrospective single-center cohort study was conducted at Bursa City Hospital between May 2025 and January 2026. A total of 466 pregnant women who delivered between 2021 and 2025 were included. Participants were classified as severe PE (n=72), mild PE (n=156), or healthy controls (n=238). Obstetric outcomes and laboratory parameters, including lipid profile and inflammatory markers, were analyzed.Results:LDL levels were significantly higher and HDL levels significantly lower in the PE groups compared with controls (p

  • Open Access

    Fetal cardiac function and doppler parameters in relation to preeclampsia severity and neonatal outcomes

    by Ebu Bekir Sıddık Yılmaz, Mustafa Rasit Özler, Erkan Sağlam, Zeynep Yalçınkaya


  • Open Access

    Prevalence and Predictors of Diabetic Retinopathy in Pregnant Women with Pregestational Diabetes

    by Serenat Yalçın, Nuray Nerez, Ebu Bekir Siddik Yilmaz, Mustafa Raşit Özler, Melike Yaylacı Kasap

    Objectives: Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and may worsen during pregnancy due to metabolic and hemodynamic changes. This study aimed to determine the prevalence of DR and identify its predictors among pregnant women with pregestational diabetes mellitus (PGDM).Materials and Methods: This retrospective cross-sectional study was conducted at a tertiary perinatal center between January and December 2024 and included 63 pregnant women with PGDM who underwent routine ophthalmologic examination during antenatal follow-up. Diabetic retinopathy was classified according to the Early Treatment Diabetic Retinopathy Study (ETDRS) criteria. Clinical and laboratory characteristics were compared between women with and without DR. Ridge-regularized logistic regression analysis was performed to identify independent predictors of DR.Results: The median maternal age was 32 years, and the mean body mass index was 29.4 ± 5.8 kg/m². Diabetic retinopathy was detected in 11 women (17.5%). Women with DR had a significantly longer duration of diabetes (median 10 vs. 5 years, p = 0.003) and higher HbA1c levels (7.9% vs. 6.8%, p = 0.02) than those without DR. Hypertension and nephropathy were more frequent among women with DR, although these differences did not reach statistical significance. In ridge-regularized logistic regression analysis, longer diabetes duration (adjusted OR = 2.9, 95% CI: 1.4–5.8) and higher HbA1c levels (adjusted OR = 1.8, 95% CI: 1.1–3.0) were independently associated with the presence of DR. The model demonstrated acceptable discriminatory performance (AUC = 0.78).Conclusion: Diabetic retinopathy was present in 17.5% of pregnant women with PGDM. Longer diabetes duration and poorer glycemic control were independently associated with the presence of DR. These findings support the importance of preconception metabolic optimization and regular ophthalmologic assessment during pregnancy, particularly in women with longstanding diabetes and suboptimal glycemic control.

  • EVALUATION OF PERINATAL OUTCOMES IN PREGNANT WOMEN WHO UNDERWENT PROPHYLACTIC AND EMERGENCY CERCLAGE

    by Ebu Bekir Siddik Yilmaz, Serenat Yalçın

    Objective: The aim of this study was to compare prophylactic and emergency (rescue) cerclage procedures in pregnant women diagnosed with cervical insufficiency and to evaluate the effects of these two approaches on pregnancy duration and perinatal outcomes. Material and Methods: Between January 2021 and December 2024, 76 pregnant women diagnosed with cervical insufficiency who underwent McDonald cerclage at a tertiary center were retrospectively reviewed. Patients were divided into two groups: those who underwent prophylactic cerclage based on their medical history and those who underwent emergency cerclage based on physical examination or ultrasonographic findings. Demographic characteristics (age, gravida, parity, history of abortion, body mass index), gestational week at cerclage, indication, interval from cerclage to delivery, gestational week at delivery, birth weight, 1st- and 5th-minute Apgar scores, mode of delivery, and neonatal intensive care unit (NICU) requirement were recorded and compared between the groups. Results: The mean gestational week at cerclage was 14.3±2.3 in the prophylactic group and 21.3±1.8 in the emergency group. The interval from cerclage to delivery and the gestational week at delivery were longer in the prophylactic group (21.89±4.80 weeks / 36.25±3.12 weeks; p

  • Open Access

    Routine Viral and Autoimmune Tests in Intrahepatic Cholestasis of Pregnancy: Are They Really Necessary?

    by Ebu Bekir Siddik Yilmaz, Serenat Yalçın

    ObjectiveTo assess whether routine viral and autoimmunehepatitis tests and hepatobiliary ultrasonography aidin diagnosing and managing intrahepatic cholestasisof pregnancy.Material and MethodThis retrospective study reviewed 120 pregnantwomen diagnosed with ICP at a tertiary care centerfrom 2020 to 2025. Demographic, clinical, andlaboratory data-including viral (HBsAg, Anti-HCV,Anti-HIV, CMV, EBV), autoimmune (ANA, SMA,AMA, Anti-LKM), and ultrasonographic findings—were analyzed to evaluate their role in diagnosis andtreatment planning.ResultsThe mean age and BMI of patients were 29.6 ± 5.3years and 29.3 ± 5.5 kg/m², respectively. The meangestational week at diagnosis was 32.5 ± 4.2, andthe mean delivery week was 36.3 ± 2.1. HBsAgpositivity was observed in 0.83% of patients, whileno cases were positive for Anti-HCV or Anti-HIV.Autoimmune markers were completely negative.Abnormal ultrasound findings were detected in 31.8%of patients, most commonly gallstones and grade 1hepatic steatosis. However, these did not result inchanges in clinical management.ConclusionRoutine testing for viral and autoimmune hepatitismarkers and hepatobiliary ultrasound in ICP patientsoffers limited diagnostic benefit and seldom affectstreatment decisions. These findings support a moretargeted and cost-effective strategy, reservingadditional tests for atypical cases or patients withtreatment resistance.

  • Open Access

    Perinatal Outcomes in Pregnancies Diagnosed with Intrahepatic Cholestasis: A Retrospective Analysis Based on the Last Three Years of Data

    by Mustafa Raşit Özler, Serenat Yalçın, Erkan Sağlam, Ebu Bekir Siddik Yilmaz, Beyda Taşkesen

    This retrospective cohort study aimed to evaluate maternal and neonatal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to compare them with matched healthy controls. A total of 70 women diagnosed with ICP and 240 controls matched for age, parity, and year were included. All participants were followed at a tertiary care center in Turkey between January 2022 and January 2025. Maternal demographics, laboratory results, obstetric characteristics, and neonatal outcomes were assessed. Subgroup analyses were conducted according to the severity of bile acid elevation and the timing of ICP diagnosis (early vs. late onset). The presence of ICP was significantly associated with increased rates of preterm delivery (35.7% vs. 5.8%, p

  • Open Access

    Predictive Value of Second Trimester HbA1c for Adverse Perinatal Outcomes: A Comparative Study in Diabetic and Non-Diabetic Pregnancies

    by Ebu Bekir Yılmaz, Serenat Eris Yalcin

    Second-trimester glycated hemoglobin (HbA1c) has been proposed as a marker of adverse pregnancy outcomes, yet its predictive value across gestational diabetes mellitus (GDM), pregestational diabetes mellitus (PGDM), and non-diabetic pregnancies remains unclear. This study assessed whether mid-pregnancy HbA1c predicts adverse perinatal outcomes and identified a clinically meaningful threshold. This retrospective cohort included 460 singleton pregnancies delivered between January 2021 and January 2025 at Bursa City Hospital. Participants were categorized as GDM (n = 203), PGDM (n = 58), or healthy controls (n = 199). HbA1c was measured at 24–28 gestational weeks. An ROC-derived cut-off of 5.3% for predicting macrosomia (>4000 g) was used for subgroup analyses. Perinatal outcomes included gestational age at delivery, delivery mode, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Correlation, ROC, and multivariate logistic regression analyses were performed. Median HbA1c levels were highest in the PGDM group (6.50%), followed by GDM (5.36%) and controls (4.93%) (p = 0.038). Women with HbA1c >5.3% had higher rates of preterm birth (p = 0.005), cesarean delivery (p = 0.012), and macrosomia (p = 0.004). ROC analysis showed moderate predictive ability for macrosomia (AUC = 0.642), preterm birth (AUC = 0.602), and cesarean delivery (AUC = 0.562). In multivariate analysis, maternal BMI independently predicted macrosomia (OR = 1.07; 95% CI: 1.01–1.14; p = 0.02), whereas HbA1c showed a positive but nonsignificant association (OR = 1.35; p = 0.13). Second-trimester HbA1c values above 5.3% were associated with increased risks of preterm birth, cesarean delivery, and macrosomia. Although HbA1c did not independently predict adverse outcomes after adjustment, it may serve as a useful adjunct biomarker for perinatal risk stratification and could contribute to multivariable prediction models.


  • Open Access

    Nutritional and inflammatory indices in gestational and pregestational diabetes: emphasis on the Controlling Nutritional Status (CONUT) score

    by Mustafa Rasit Ozler, Erkan Saglam, Serenat Yalcin, Ebubekir Siddik Yilmaz, Nuray Nerez

    Objective: To comparatively evaluate the prognostic value of nutritional and inflammatory indices in gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (PGDM), and to determine their association with adverse perinatal outcomes. Methods: This retrospective study included 280 pregnant women followed at a tertiary care center between January 2020 and December 2024. Participants were categorized into three groups: GDM ( n = 90), PGDM ( n = 80), and healthy controls ( n = 110). Nutritional status was assessed using the Controlling Nutritional Status (CONUT) and Prognostic Nutritional Index (PNI) scores. Inflammatory indices including NLR, SII, SIRI, PIV, and others were calculated. Perinatal outcomes such as preterm birth, NICU admission, and Composite Adverse Perinatal Outcomes (CAPO) were recorded. ROC analysis was used to determine the predictive power of the biomarkers. Results: The PGDM group demonstrated significantly higher CONUT scores and lower PNI scores compared to the other groups ( p < 0.001). Among inflammatory markers, NLR, SII, SIRI, and PIV were significantly elevated in PGDM cases. ROC analyses revealed that the CONUT score had strong discriminative ability in differentiating diabetic (GDM and PGDM) from non-diabetic pregnancies (AUC = 0.787; specificity = 89.1%), while the PNI score showed limited discriminative capacity (AUC = 0.291). Inflammatory indices also demonstrated moderate predictive value, particularly among PGDM cases. Higher CONUT and inflammatory scores were associated with increased rates of preterm birth, NICU admission, and CAPO ( p < 0.001). Conclusion: Nutritional and inflammatory disturbances are more prominent in PGDM than in GDM. The CONUT score and selected inflammatory indices may serve as valuable tools for early risk stratification in diabetic pregnancies. Integration of these parameters into clinical decision-making may improve perinatal outcomes, particularly in high-risk groups such as PGDM.